XSHG
600381
Market cap299mUSD
May 30, Last price
3.77CNY
1D
-1.57%
1Q
-7.14%
Jan 2017
-75.55%
Name
Qinghai Spring Medicinl Rsrcs Tech CoLTD
Chart & Performance
P/E
—
P/S
10.09
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.41%
Rev. gr., 5y
-8.48%
Revenues
214m
+33.52%
Net income
-268m
CFO
24m
Dividend
May 21, 20030.052371 CNY/sh
Profile
Qinghai Spring Medicinal Resources Technology Co., Ltd. research and development, production, and sale of cordyceps products. It is also involved in the sale of beverages and aquatic products; advertising; and foreign investment business. The company was founded in 2003 and is based in Xining, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | |||||||||
Revenues | 213,877 33.52% | 160,178 25.37% | |||||||
Cost of revenue | 288,047 | 235,189 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | (74,171) | (75,011) | |||||||
NOPBT Margin | |||||||||
Operating Taxes | 5,930 | ||||||||
Tax Rate | |||||||||
NOPAT | (80,101) | (75,011) | |||||||
Net income | (267,865) | ||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | 1,950 | ||||||||
Long-term debt | 19,668 | 5,891 | |||||||
Deferred revenue | 1,628 | ||||||||
Other long-term liabilities | 1,016 | 1 | |||||||
Net debt | (242,263) | (389,819) | |||||||
| Cash flow | |||||||||
Cash from operating activities | 23,917 | ||||||||
CAPEX | (13,531) | ||||||||
Cash from investing activities | 36,159 | ||||||||
Cash from financing activities | (8,531) | (895) | |||||||
FCF | 29,469 | 84,565 | |||||||
| Balance | |||||||||
Cash | 172,930 | 169,347 | |||||||
Long term investments | 89,001 | 228,313 | |||||||
Excess cash | 251,237 | 389,651 | |||||||
Stockholders' equity | 923,359 | 1,295,557 | |||||||
Invested Capital | 1,026,931 | 1,149,740 | |||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | 582,316 | 587,061 | |||||||
Price | 7.73 -37.21% | 12.31 46.03% | |||||||
Market cap | 4,501,301 -37.71% | 7,226,718 46.03% | |||||||
EV | 4,261,290 | 6,836,899 | |||||||
EBITDA | (44,376) | (33,500) | |||||||
EV/EBITDA | |||||||||
Interest | 962 | 92 | |||||||
Interest/NOPBT | |||||||||